COM:RVLPHARMA
RVL Pharmaceuticals
- Stock
Last Close
0.04
20/10 20:00
Market Cap
3.14M
Beta: -
Volume Today
63.96M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | ||
|---|---|---|---|---|---|---|---|---|
average inventory | 18.39M - | 20.66M 12.35% | 22.84M 10.54% | 11.57M 49.36% | 1.33M 88.46% | 811K 39.23% | ||
average payables | 35.52M - | 30.47M 14.23% | 16.68M 45.25% | 5.81M 65.16% | 3.45M 40.59% | 3.09M 10.44% | ||
average receivables | 41.48M - | 47.03M 13.39% | 50.17M 6.67% | 23.53M 53.10% | 2.64M 88.78% | 2.58M 2.23% | ||
book value per share | 10.86 - | 9.78 9.89% | 8.48 13.34% | 2.19 74.16% | 1.55 29.36% | 1.14 26.38% | 0.57 50.06% | |
capex per share | -0.37 - | -0.16 56.72% | -0.09 43.12% | -0.08 15.77% | -0.05 32.97% | -0.03 48.80% | -0.01 68.35% | |
capex to depreciation | -0.68 - | -0.15 78.02% | -0.05 65.78% | -0.07 39.39% | -0.15 110.51% | -0.22 46.24% | -2.01 819.96% | |
capex to operating cash flow | 0.36 - | -0.12 133.52% | -0.11 7.46% | -0.12 9.01% | -0.18 48.14% | 0.03 118.27% | 0.02 38.91% | |
capex to revenue | -0.07 - | -0.03 61.52% | -0.02 44.00% | -0.02 7.03% | -0.11 571.21% | -0.10 9.80% | -0.02 85.15% | |
cash per share | 0.46 - | 0.81 77.61% | 1.56 92.99% | 1.83 17.01% | 1.88 2.72% | 0.65 65.65% | 0.50 23.21% | |
days of inventory on hand | 57.65 - | 49.41 14.29% | 63.53 28.58% | 69.66 9.65% | 202.95 191.34% | 84.54 58.34% | 30.26 64.20% | |
days payables outstanding | 101.64 - | 105.17 3.47% | 64.80 38.38% | 27.78 57.14% | 346.71 1,148.22% | 381.04 9.90% | 92.91 75.62% | |
days sales outstanding | 75.72 - | 55.90 26.17% | 78.10 39.71% | 66.78 14.50% | 41.40 38.00% | 44.49 7.45% | 22.25 49.98% | |
debt to assets | 0.34 - | 0.36 7.68% | 0.34 6.68% | 0.59 74.60% | 0.60 1.27% | 0.33 44.87% | 0.45 35.83% | |
debt to equity | 0.71 - | 0.76 8.14% | 0.70 8.43% | 2.38 240.19% | 2.36 0.90% | 0.62 73.70% | 1.13 81.21% | |
dividend yield | 0.07 - | 0.00 - | ||||||
earnings yield | -0.12 - | -0.13 7.96% | -0.31 141.79% | -0.74 136.76% | -0.36 51.87% | -1.14 219.74% | -0.51 54.87% | |
enterprise value | 658.70M - | 635.23M 3.56% | 548.89M 13.59% | 543.48M 0.99% | 357.45M 34.23% | 79.94M 77.64% | 113.52M 42.00% | |
enterprise value over ebitda | 30.53 - | 10.11 66.89% | 6.24 38.23% | 8.92 42.83% | -8.77 198.34% | -1.09 87.62% | -3.14 189.08% | |
ev to operating cash flow | -14.71 - | 10.98 174.68% | 14.61 33.06% | 16.19 10.79% | 20.32 25.51% | -1.46 107.19% | -3.00 105.55% | |
ev to sales | 3.02 - | 2.58 14.27% | 2.08 19.47% | 2.26 8.78% | 12.88 468.66% | 4.57 64.52% | 2.28 50.02% | |
free cash flow per share | -1.42 - | 1.19 183.88% | 0.74 37.91% | 0.56 23.59% | 0.24 57.73% | -0.84 452.04% | -0.43 48.82% | |
free cash flow yield | -0.17 - | 0.15 183.88% | 0.10 34.71% | 0.08 15.28% | 0.06 28.29% | -0.78 1,442.98% | -0.38 50.65% | |
graham net net | -10.50 - | -9.22 12.21% | -6.33 31.36% | -3.99 36.89% | -2.63 34.03% | -0.33 87.37% | -0.34 1.10% | |
graham number | 15.44 - | 15.23 1.37% | 21.50 41.16% | 15.97 25.72% | 7.15 55.23% | 5.62 21.45% | 2.71 51.65% | |
income quality | 1.07 - | -1.28 219.59% | -0.34 73.27% | -0.12 63.82% | -0.22 78.37% | 0.84 481.46% | 0.73 13.24% | |
intangibles to total assets | 0.87 - | 0.83 4.51% | 0.74 10.84% | 0.55 25.97% | 0.25 55.44% | 0.57 134.19% | 0.54 5.47% | |
interest coverage | -1.59 - | -1.79 12.89% | -4.74 164.45% | 0.22 104.56% | -15.08 7,075.98% | -20.04 32.90% | -14.69 26.70% | |
interest debt per share | 8.15 - | 8.16 0.14% | 6.40 21.61% | 5.57 12.98% | 3.72 33.15% | 0.77 79.39% | 0.67 12.02% | |
inventory turnover | 6.33 - | 7.39 16.67% | 5.75 22.23% | 5.24 8.80% | 1.80 65.68% | 4.32 140.06% | 12.06 179.36% | |
invested capital | 0.71 - | 0.76 8.14% | 0.70 8.43% | 2.38 240.19% | 2.36 0.90% | 0.62 73.70% | 1.13 81.21% | |
market cap | 349.23M - | 349.29M 0.01% | 350.89M 0.46% | 366.05M 4.32% | 249.89M 31.73% | 72.74M 70.89% | 100.57M 38.26% | |
net current asset value | -419.09M - | -351.29M 16.18% | -239.41M 31.85% | -175.92M 26.52% | -103.94M 40.92% | -8.56M 91.77% | -20.44M 138.86% | |
net debt to ebitda | 14.34 - | 4.55 68.28% | 2.25 50.50% | 2.91 29.26% | -2.64 190.64% | -0.10 96.30% | -0.36 266.00% | |
net income per share | -0.98 - | -1.05 7.96% | -2.42 129.92% | -5.17 113.55% | -1.47 71.63% | -1.23 16.19% | -0.58 53.20% | |
operating cash flow per share | -1.05 - | 1.35 229.11% | 0.83 38.53% | 0.64 22.73% | 0.29 54.76% | -0.81 380.20% | -0.42 48.18% | |
payables turnover | 3.59 - | 3.47 3.35% | 5.63 62.29% | 13.14 133.29% | 1.05 91.99% | 0.96 9.01% | 3.93 310.12% | |
receivables turnover | 4.82 - | 6.53 35.45% | 4.67 28.42% | 5.47 16.95% | 8.82 61.29% | 8.20 6.93% | 16.40 99.93% | |
research and ddevelopement to revenue | 0.13 - | 0.17 30.58% | 0.17 4.61% | 0.13 18.74% | 0.48 258.13% | 0.40 17.88% | 0.08 79.86% | |
return on tangible assets | -0.34 - | -0.31 8.94% | -0.54 75.29% | -1.30 142.21% | -0.32 75.54% | -1.34 323.00% | -0.88 34.58% | |
revenue per share | 5.10 - | 5.73 12.48% | 5.82 1.57% | 4.58 21.30% | 0.46 90.01% | 0.26 43.23% | 0.55 113.10% | |
roe | -0.09 - | -0.11 19.80% | -0.29 165.31% | -2.36 726.50% | -0.95 59.84% | -1.08 13.84% | -1.01 6.30% | |
roic | -0.03 - | -0.04 14.48% | -0.14 276.02% | 0.01 106.52% | -0.18 2,107.20% | -0.64 251.85% | -0.42 34.87% | |
sales general and administrative to revenue | ||||||||
shareholders equity per share | 10.86 - | 9.78 9.89% | 8.48 13.34% | 2.19 74.16% | 1.55 29.36% | 1.14 26.38% | 0.57 50.06% | |
stock based compensation to revenue | 0.12 - | 0.30 156.90% | 0.01 97.52% | 0.02 175.70% | 0.18 763.38% | 0.43 144.60% | 0.08 81.14% | |
tangible asset value | -388.90M - | -318.93M 17.99% | -207.40M 34.97% | -140.13M 32.43% | 2.92M 102.08% | -6.32M 316.65% | -18.65M 194.97% | |
tangible book value per share | -9.08 - | -7.44 18.00% | -4.58 38.45% | -2.68 41.58% | 0.05 101.80% | -0.09 295.09% | -0.21 121.25% | |
working capital | -23.62M - | -9.53M 59.64% | 58.36M 712.17% | 96.69M 65.67% | 117.37M 21.38% | 39.27M 66.54% | 37.25M 5.14% |
All numbers in (except ratios and percentages)